WelcomeUser Guide
ToSPrivacyCanary
DonateBugsLicense

©2025 Poal.co

590

Its a "good prognosis" type. And my mom is trying to talk her out of doing chemo poison treatment after the surgery.. as the (((doctors))) are going to tell her its "recommended"...

But that would require her to be able to distrust in the "science monster". And i doubt that. She has three kids and just got divorced.. I'm afraid its a sad time ahead..

Its a "good prognosis" type. And my mom is trying to talk her out of doing chemo poison treatment after the surgery.. as the (((doctors))) are going to tell her its "recommended"... But that would require her to be able to distrust in the "science monster". And i doubt that. She has three kids and just got divorced.. I'm afraid its a sad time ahead..

(post is archived)

[–] 2 pts

The "recovery rate" for cancer is another fraught area. As more and more screening is being conducted, they are picking up cancers that are smaller and much less rapidly growing. Basically, there are three categories of cancer: turbo-cancer that grows so fast that by the time you find it you're basically going to die in a year or so, treatment does little to nothing for this, normal speed cancer, which grows at a steady pace and is responsive to treatment, and slow cancer, which grows so slowly that you're likely to die of old age before it ever becomes a problem. Treatment for this type of cancer is pointless and the side effects of the treatment are often much worse than the cancer itself.

Screening increases the detection of the last two categories. But, the mortality rate from the last category is very low. The issue is that there is no differentiation of these categories of cancer in the mortality figures, so the very slow growing cancers artificially increase the 5 year survival statistics.

There's an interesting book on this, called Overdiagnosed, which goes into how the over use of screening tests is leading to unnecessary treatment for diseases, including cancer, that is resulting in an overall increase in all cause mortality. Effectively, they are treating people with drugs that might be appropriate if the condition they had was life threatening, but they really don't have a life threatening condition. So the iatrogenic harms are felt, but there is no benefit.

[–] 0 pt

Interesting. It sounds like the prudent thing is to get a second diagnosis and ask if the cancer is highly malignant or relatively benign.

[–] 2 pts

Yeah, depending on the type of cancer, you might be able to monitor it and if it's not growing or spreading, then doing nothing may be a better option. That being said, I wouldn't act based on my advice, but getting a second opinion from a trained specialist would be advisable.

There is a perverse interest in the cancer treatment industry though, to treat non-threatening cancers, since the "survival rate" of those (other than people who die from the treatment) is very high. That makes the treatment look much better than it really is.